Access to advanced tools for determining 3D structures of biological molecules
GM/CA@APS: A Macromolecular Crystallography Resource
This study is all about using advanced technology to help scientists figure out the 3D shapes of important biological molecules, which can lead to new treatments and therapies for patients.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Uchicago Argonne, LLC NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10929359 on NIH RePORTER |
What this research studies
This research provides access to state-of-the-art macromolecular crystallography facilities that allow scientists to determine the 3D atomic structures of important biological molecules. By utilizing advanced X-ray beamlines, researchers can analyze samples quickly and accurately, which is crucial for understanding complex biological processes and diseases. The facility supports a wide range of experiments, including those that require precise energy adjustments for optimal data collection. Patients may benefit indirectly as this research contributes to the development of new treatments and therapies based on structural biology insights.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that have a genetic or molecular basis, such as certain cancers or genetic disorders.
Not a fit: Patients with conditions that are not related to molecular structures or do not involve biological macromolecules may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding diseases at the molecular level, potentially resulting in new therapeutic strategies.
How similar studies have performed: Other research utilizing macromolecular crystallography has shown significant success in elucidating molecular structures, leading to advancements in drug design and understanding of various diseases.
Where this research is happening
Chicago, United States
- Uchicago Argonne, LLC — Chicago, United States (Active)
Researchers
- Principal investigator: Fischetti, Robert F. — Uchicago Argonne, LLC
- Study coordinator: Fischetti, Robert F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.